Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma (2012)

by S Hagiwara, M Kudo, T Nagai, T Inoue, K Ueshima, N Nishida, T Watanabe, T Sakurai
Venue:Br J Cancer